Agios Pharmaceuticals (AGIO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Agios Pharmaceuticals (AGIO) is Neutral.

The composite score behind that read is -0.06, weighing +0.09 of bullish evidence against -0.22 bearish.

Agios Pharmaceuticals last closed at $31.81, -0.34% on the session.

Against the IVW growth benchmark the position is -1.14% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

6 graded predictions for AGIO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Agios Pharmaceuticals in the 22nd percentile on return on equity, where 100 is best.

Agios Pharmaceuticals is classified under Health Care / Biotechnology, with a market capitalisation of $1.91B.

StockMap tracks Agios Pharmaceuticals as the 93rd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Agios Pharmaceuticals ranks 143rd of 381 in the group, against a group median of -0.08.